Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Evoke Pharma Inc EVOK

Healthcare
Evoke Pharma, Inc. is a specialty pharmaceutical company. The Company is focused primarily on the development and commercialization of drugs to treat gastrointestinal (GI) disorders and diseases. The Company operates through the development and commercialization of pharmaceutical products. It is developing its product, Gimoti (metoclopramide) nasal spray, the first and only nasally administered... see more

Recent & Breaking News (NDAQ:EVOK)

The Daily Biotech Pulse: PhaseBio Gets Breakthrough Therapy Designation, FDA Shoots Down Zogenix Epilepsy Regulatory Filing

Benzinga.com  April 9, 2019

The Daily Biotech Pulse: Merrimack Pulls The Plug On Early-Stage Trial, Legal Headache For Novartis-Amgen Migraine Partnership

Benzinga.com  April 5, 2019

The Daily Biotech Pulse: Recro Restructures, Biotechs Raise Proceeds In Droves, Silk Road, NGM Biopharma To Debut

Benzinga.com  April 4, 2019

The Daily Biotech Pulse: Advaxis Offering, Roche's Spark Tender Offer Extended, Ascendis Earnings

Benzinga.com  April 3, 2019

Mid-Afternoon Market Update: ADMA Biologics Jumps On FDA Nod For Immunodeficiency Therapy; Evoke Pharma Shares Plummet

Benzinga.com  April 2, 2019

Mid-Day Market Update: Crude Oil Up Over 1%; Apyx Medical Shares Slide

Benzinga.com  April 2, 2019

Mid-Morning Market Update: Markets Edge Lower; Walgreens Misses Q2 Views

Benzinga.com  April 2, 2019

32 Stocks Moving In Tuesday's Pre-Market Session

Benzinga.com  April 2, 2019

A Peek Into The Markets: US Stock Futures Flat Ahead Of Durable-Goods Orders Data

Benzinga.com  April 2, 2019

Evoke Pharma Receives Complete Response Letter and Recommendations to Address Deficiencies from FDA for Gimoti™ NDA

GlobeNewswire April 2, 2019

The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials, Earnings And IPOs

Benzinga.com  March 30, 2019

Attention Biotech Investors: Mark Your Calendar For These April PDUFA Dates

Benzinga.com  March 29, 2019

56 Stocks Moving In Thursday's Mid-Day Session

Benzinga.com  March 14, 2019

Evoke Pharma Submits Response to FDA Review Letter for Gimoti™ NDA

GlobeNewswire March 14, 2019

Evoke Pharma Reports Fourth Quarter and Full Year 2018 Financial Results and FDA Communication

GlobeNewswire March 6, 2019

Mid-Day Market Update: U.S. Stocks Turn Negative; Dow Down Over 350 Points

Benzinga.com  March 4, 2019

Mid-Morning Market Update: Markets Open Higher; Childrens Place Misses Q4 Expectations

Benzinga.com  March 4, 2019

The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials, Earnings, IPOs

Benzinga.com  March 3, 2019

Evoke Pharma Signs Commercial and Financial Agreement for its Lead Product Gimoti™ in the U.S. with Novos Growth Partners

GlobeNewswire January 7, 2019

Evoke Pharma Reports Third Quarter 2018 Results

GlobeNewswire November 13, 2018